精確搜索結果
- Applications and Industries
-
- 內容類型
-
內容類型
- Analysis Platform
-
產品
- 語言
-
語言
This quick reference guide provides detailed instructions on how to prepare, perform, and evaluate the impedance-based TCID50 protocol using the xCELLigence RTCA Software Pro Virology module to determine viral titer
- 文件出版號: 5994-7860EN
- 創(chuàng)建日期: 18 三月 2025
- 143 KB
In this application note, Antibody Analytics (Motherwell, UK) integrates IndEx-2, an advanced in vitro cell-based platform engineered to modulate the expression of one or two target antigens across a range of biologically relevant levels, with the...
- 文件出版號: 5994-7175EN
- 創(chuàng)建日期: 06 六月 2024
- 2 MB
This application note demonstrates the signal recording of the xCELLigence RTCA eSight, enabling visualization and quantification of cell migration and invasion and the speed of wound closure healing.
- 文件出版號: 5994-6887EN
- 創(chuàng)建日期: 08 十二月 2023
- 13 MB
This application note describes a novel real-time co-culture assay using RTCA eSight for interrogating NK92 immune cell invasion and cytotoxicity and migratory kinetic profiles based on ECM and effects of TME.
- 文件出版號: 5994-6888EN
- 創(chuàng)建日期: 29 十一月 2023
- 3 MB
This application note evaluates the Agilent xCELLigence RTCA eSight as a tool to monitor BiTE antibody-mediated cancer cell lysis.
- 文件出版號: 5994-6004EN
- 創(chuàng)建日期: 21 四月 2023
- 2 MB
xCELLigence Immunotherapy IMT Assay (anti-CD9) Tethering Kit and Sample Kit Protocol
- 文件出版號: 5994-3234EN
- 創(chuàng)建日期: 15 三月 2022
- 634 KB
This study used the Agilent xCELLigence RTCA CardioECR system with human iPSC-derived cardiomyocytes (hiPSC-CMs) to evaluate cardiac safety/toxicity of antiviral drugs.
- 文件出版號: 5994-4325EN
- 創(chuàng)建日期: 15 十一月 2021
- 2 MB
A demonstration of the use of the Agilent xCELLigence RTCA CardioECR system to compare functional profiles of contractility and electrophysiology between an PS-iPSC-CM disease model and its isogenic control.
- 文件出版號: 5994-3112EN
- 創(chuàng)建日期: 09 九月 2021
- 3 MB
Noninvasive and continuous monitoring of the perturbation of cellular growth following exposure to the cumulative toxicants present in water samples.
- 文件出版號: 5994-3712EN
- 創(chuàng)建日期: 07 九月 2021
- 916 KB
xCELLigence Immunotherapy IMT Assay (anti-CD29) Tethering Kit and Sample Kit Protocol
- 文件出版號: 5994-3237
- 創(chuàng)建日期: 14 七月 2021
- 671 KB
xCELLigence Immunotherapy IMT Assay (anti-CD40) Tethering Kit and Sample Kit Protocol
- 文件出版號: 5994-3238
- 創(chuàng)建日期: 14 七月 2021
- 727 KB
xCELLigence Immunotherapy IMT Assay (anti-CD19) Tethering Kit and Sample Kit Protocol
- 文件出版號: 5994-3235
- 創(chuàng)建日期: 14 七月 2021
- 768 KB
xCELLigence Immunotherapy IMT Assay (anti-CD71) Tethering Kit and Sample Kit Protocol
- 文件出版號: 5994-3236
- 創(chuàng)建日期: 14 七月 2021
- 749 KB
A demonstration of how the Agilent xCELLigence RTCA eSight real-time imaging platform can be used to monitor induction of the unfolded protein response using a genetically encoded fluorescent sensor.
- 文件出版號: 5994-3071EN
- 創(chuàng)建日期: 16 四月 2021
- 4 MB
A demonstration of how the Agilent xCELLigence RTCA eSight real-time imaging platform can be used to monitor phagocytosis, using a model system comprising macrophages and E. coli cells conjugated to a pH-sensitive fluorescent dye.
- 文件出版號: 5994-3019EN
- 創(chuàng)建日期: 16 四月 2021
- 6 MB
A demonstration of how the eSight combines the strengths of real-time impedance monitoring with those of live cell imaging, to increase the information richness of your proliferation assays while simultaneously reducing the workload.
- 文件出版號: 5994-3017EN
- 創(chuàng)建日期: 17 二月 2021
- 6 MB
To determine if the stimulation of endogenously expressed GPCRs can be monitored by the xCELLigence system, cells were stimulated with various receptor agonists, triggering either Gs-, Gi-, or Gq-mediated downstream signals.
- 文件出版號: 5994-1940EN
- 創(chuàng)建日期: 02 二月 2021
- 3 MB
Using the Agilent xCELLigence RTCA eSight to continuously monitor CAR T cell-mediatedkilling of cancer cells over the course of multiplae days.
- 文件出版號: 5994-1712EN
- 創(chuàng)建日期: 09 十一月 2020
- 4 MB
In this application note, we used the xCELLigence RTCA CardioECR system (CardioECR system) in conjunction with hiPS-CMs for the assessment of preclinical cardiac risks.
- 文件出版號: 5994-2076EN
- 創(chuàng)建日期: 16 六月 2020
- 5 MB
This application note presents a method for improving human-induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) maturation using the Agilent xCELLigence RTCA ePacer system.
- 文件出版號: 5994-1552EN
- 創(chuàng)建日期: 16 六月 2020
- 5 MB